Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Poveda

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
Applied Biochemistry and Biotechnology|October 10, 2017
Correction to: Malachite Green and Crystal Violet Decolorization by Ganoderma lucidum and Pleurotus ostreatus Supernatant and by rGlLCC1 and rPOXA 1B Concentrates: Molecular Docking AnalysisEdwin D Morales-Álvarez, Claudia M Rivera-Hoyos, Sergio A Poveda-Cuevas, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2008
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)N S Reed, C Mangioni, H Malmström, et al.
Biochemistry|October 3, 2002
Tyrosine phosphorylation of the inactivating peptide of the shaker B potassium channel: a structural-functional correlateJ A Encinar, A M Fernández, M L Molina, et al.
Biochimica Et Biophysica Acta|October 2, 2012
Detergent-labile, supramolecular assemblies of KcsA: relative abundance and interactions involvedA Marcela Giudici, M Luisa Molina, José L Ayala, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2015
Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in patients with advanced ovarian cancer: exploratory analysis of the phase 3 OVA-301 studyB J Monk, P Ghatage, T Parekh, et al.
British Journal of Cancer|May 25, 2006
Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS studyA López-Pousa, R Losa, J Martín, et al.
The Journal of Biological Chemistry|September 4, 2015
Competing Lipid-Protein and Protein-Protein Interactions Determine Clustering and Gating Patterns in the Potassium Channel from Streptomyces lividans (KcsA)M Luisa Molina, A Marcela Giudici, José A Poveda, et al.
Biochemistry|April 19, 2012
Contribution of ion binding affinity to ion selectivity and permeation in KcsA, a model potassium channelM L Renart, E Montoya, A M Fernández, et al.
Sarcoma|June 4, 2008
Phase II Clinical Trial With Pegylated Liposomal Doxorubicin (CAELYX(R)/Doxil(R)) and Quality of Life Evaluation (EORTC QLQ-C30) in Adult Patients With Advanced Soft Tissue Sarcomas: A study of the Spanish Group for Research in Sarcomas (GEIS)A Poveda, A López-Pousa, J Martín, et al.
Biochemistry|May 21, 2010
Occupancy of nonannular lipid binding sites on KcsA greatly increases the stability of the tetrameric proteinI Triano, F N Barrera, M L Renart, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Applied Biochemistry and Biotechnology|October 10, 2017
Correction to: Malachite Green and Crystal Violet Decolorization by Ganoderma lucidum and Pleurotus ostreatus Supernatant and by rGlLCC1 and rPOXA 1B Concentrates: Molecular Docking AnalysisEdwin D Morales-Álvarez, Claudia M Rivera-Hoyos, Sergio A Poveda-Cuevas, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2008
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)N S Reed, C Mangioni, H Malmström, et al.
Biochemistry|October 3, 2002
Tyrosine phosphorylation of the inactivating peptide of the shaker B potassium channel: a structural-functional correlateJ A Encinar, A M Fernández, M L Molina, et al.
Biochimica Et Biophysica Acta|October 2, 2012
Detergent-labile, supramolecular assemblies of KcsA: relative abundance and interactions involvedA Marcela Giudici, M Luisa Molina, José L Ayala, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2015
Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in patients with advanced ovarian cancer: exploratory analysis of the phase 3 OVA-301 studyB J Monk, P Ghatage, T Parekh, et al.
British Journal of Cancer|May 25, 2006
Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS studyA López-Pousa, R Losa, J Martín, et al.
The Journal of Biological Chemistry|September 4, 2015
Competing Lipid-Protein and Protein-Protein Interactions Determine Clustering and Gating Patterns in the Potassium Channel from Streptomyces lividans (KcsA)M Luisa Molina, A Marcela Giudici, José A Poveda, et al.
Biochemistry|April 19, 2012
Contribution of ion binding affinity to ion selectivity and permeation in KcsA, a model potassium channelM L Renart, E Montoya, A M Fernández, et al.
Sarcoma|June 4, 2008
Phase II Clinical Trial With Pegylated Liposomal Doxorubicin (CAELYX(R)/Doxil(R)) and Quality of Life Evaluation (EORTC QLQ-C30) in Adult Patients With Advanced Soft Tissue Sarcomas: A study of the Spanish Group for Research in Sarcomas (GEIS)A Poveda, A López-Pousa, J Martín, et al.
Biochemistry|May 21, 2010
Occupancy of nonannular lipid binding sites on KcsA greatly increases the stability of the tetrameric proteinI Triano, F N Barrera, M L Renart, et al.
Pageof 11